Pharmacytimes: Condition Center: CNS http://www.pharmacytimes.com/condition-resources/cns/condition-rss CNS en-us Sat, 16 Dec 2017 08:40:03 UTC Sat, 16 Dec 2017 08:40:03 UTC Perspectives for the Pharmacist in Epilepsy Management: Considerations for the Use of FYCOMPA(R) (perampanel) Tablets and Oral Suspension, CIII http://www.pharmacytimes.com/publications/issue/2017/September2017/R867_September2017 10:27 AM, Wed September 13, 2017 Amino Acid L-Serine in Preventing Neurodegenerative Diseases Associated with BMAA http://www.pharmacytimes.com/contributor/adam-remick/2017/09/amino-acid-l-serine-in-preventing-neurodegenerative-diseases-associated-with-bmaa Insights into possible treatments for disorders that range from demyelination to plaque formation and misfolded proteins. 9:41 PM, Mon September 4, 2017 CDC: Epilepsy Rates Increasing Among Adults, Children http://www.pharmacytimes.com/news/cdc-epilepsy-rates-increasing-among-adults-children For the first time, epilepsy rate estimates have been available for every state, totaling in at least 3.4 million individuals living with the disorder. 10:51 AM, Wed August 23, 2017 Epileptic Patients Face Heightened Suicide Risk http://www.pharmacytimes.com/publications/issue/2017/March2017/epileptic-patients-face-heightened-suicide-risk Patients with epilepsy are more likely to commit suicide than individuals without the condition, according to the results of a recent CDC study. 3:47 PM, Mon March 20, 2017 Antipsychotic Drugs Could Increase Mortality in Parkinson's Disease Patients http://www.pharmacytimes.com/publications/issue/2017/March2017/antipsychotic-drugs-could-increase-mortality-in-parkinsons-disease-patients Antipsychotic medications may do more harm than good in patients with Parkinson’s disease, with a recent study indicating that the use of these drugs can lead to a heightened mortality risk in this population. 3:47 PM, Mon March 20, 2017 Early Treatment of MS Signs May Slow Disease Progression http://www.pharmacytimes.com/publications/issue/2017/March2017/early-treatment-of-ms-signs-may-slow-disease-progression A recent study has suggested that starting patients on multiple sclerosis medication soon after they show initial signs of the disease could prolong the time before the condition becomes fully diagnosable. 3:47 PM, Mon March 20, 2017 Epilepsy: What You and Your Patients Need to Know http://www.pharmacytimes.com/publications/issue/2017/March2017/epilepsy-what-you-and-your-patients-need-to-know The year 2016 was big for neurology, particularly in the realm of epilepsy. 1:08 PM, Mon March 20, 2017 Self-Care for Central Nervous System Function http://www.pharmacytimes.com/publications/issue/2017/March2017/selfcare-for-central-nervous-system-function Which OTC products should these pharmacists recommend? 12:03 PM, Mon March 20, 2017 What Role Do Zebrafish Models Play in Epilepsy Treatment? http://www.pharmacytimes.com/news/what-role-do-zebrafish-models-play-in-epilepsy-treatment Scientists have discovered a potential new drug therapy by using a zebrafish model of epilepsy.  9:00 AM, Tue February 14, 2017 Eisai Begins 2 Phase 3 Trials to Further Assess FYCOMPA http://www.pharmacytimes.com/product-news/eisai-begins-2-phase-3-trials-to-further-assess-fycompa- Eisai announced the beginning of 2 multi-center, global phase 3 clinical trials assessing FYCOMPA (perampanel). 7:00 AM, Wed November 2, 2016 A Brief Review of Brand-Name Antiepileptic Drugs http://www.pharmacytimes.com/contributor/mel-seabright-pharmd-mba/2016/05/a-brief-review-of-brand-name-antiepileptic-drugs Epilepsy is a brain disorder that predisposes an individual to recurrent unprovoked seizures. 4:17 AM, Wed May 18, 2016 New Fycompa Oral Suspension Formulation Receives FDA Approval http://www.pharmacytimes.com/contributor/anyssa-garza/2016/05/new-fycompa-oral-suspension-formulation-receives-fda-approval Initially approved in tablet form in 2012, perampanel (Fycompa) is now available as an oral suspension. 10:04 PM, Tue May 17, 2016 Self-Care for Disorders Related to the Central Nervous System http://www.pharmacytimes.com/publications/issue/2016/March2016/Self-Care-for-Disorders-Related-to-the-Central-Nervous-System Which OTC products should these pharmacists recommend? 10:30 PM, Mon March 14, 2016 More Women with Epilepsy Should Consider Contraceptives http://www.pharmacytimes.com/resource-centers/womens-health/more-women-with-epilepsy-should-consider-contraceptives Because many antiepileptic drugs have teratogenic potential, health care providers commonly recommend contraceptives to women with epilepsy. 9:37 PM, Mon March 7, 2016 FDA Approves New Epileptic Seizure Treatment http://www.pharmacytimes.com/product-news/fda-approves-new-seizure-treatment-for-epilepsy-patients The FDA has approved UCB's brivaracetam (Briviact) as an adjunctive treatment for partial-onset seizures in patients aged 16 years and older with epilepsy. 12:32 AM, Fri February 19, 2016 3 Things Pharmacists Should Know About Neglected Tropical Diseases http://www.pharmacytimes.com/contributor/matthew-romo-pharmd-mph/2016/01/3-things-pharmacists-should-know-about-neglected-tropical-diseases Since many neglected tropical diseases never appear in pharmacy school textbooks, here are some things you need to know about them. 3:31 AM, Mon January 11, 2016 Top 5 Natural Epilepsy Treatments http://www.pharmacytimes.com/news/top-5-natural-epilepsy-treatments Pharmacists can help patients take a big step towards managing their epilepsy by identifying epileptic triggers. 8:30 PM, Tue December 22, 2015 Epilepsy Treatment Should Immediately Follow First Seizure http://www.pharmacytimes.com/publications/issue/2015/December2015/Epilepsy-Treatment-Should-Immediately-Follow-First-Seizure A guideline recently released by the American Academy of Neurology and the American Epilepsy Society has clarified that antiepileptic medication should be administered immediately after a patient's first seizure in order to reduce the risk of having another seizure within 2 years. 4:00 AM, Mon December 21, 2015 Children Who Undergo Epilepsy Surgery May Struggle Academically http://www.pharmacytimes.com/publications/issue/2015/December2015/Children-Who-Undergo-Epilepsy-Surgery-May-Struggle-Academically Although brain surgery is a common option for patients with epilepsy who do not respond to medication, a recent study has found that children who undergo this procedure may experience difficulties in school afterward. 3:33 AM, Mon December 21, 2015 Retrospective DUR Curbs Unsafe Opioid Combo Therapy http://www.pharmacytimes.com/resource-centers/pain/retrospective-dur-curbs-unsafe-opioid-combo-therapy Retrospective drug utilization review programs can reduce potentially unsafe concomitant opioid and central nervous system (CNS) medication use. 8:00 PM, Tue November 24, 2015